BHC
Bausch Health Companies Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth +5.6% ·
share flow -30.0% ·
net new positions 0.0%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -5 | 75.64M | $382.99M | +3 | −7 |
| Q1 2026 | 85 | -6 | 79.75M | $438.97M | +2 | −9 |
| Q4 2025 | 92 | +1 | 89.74M | $627.51M | +2 | — |
| Q3 2025 | 19 | +1 | 25.30M | $166.30M | +2 | −2 |
| Q2 2025 | 16 | -1 | 54.52M | $364.89M | — | −1 |
| Q1 2025 | 15 | +1 | 47.24M | $307.27M | +2 | −1 |
| Q4 2024 | 14 | +1 | 50.10M | $405.72M | +1 | — |
| Q3 2024 | 13 | +1 | 47.82M | $391.50M | +2 | −1 |
| Q2 2024 | 12 | — | 55.66M | $388.80M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 12.24M | +4.0% | $78.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passive) | 12.24M | +4.0% | $78.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passive) | 12.24M | +4.0% | $78.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passive) | 12.24M | +4.0% | $78.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passive) | 12.24M | +4.0% | $78.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Goldman Sachs Group ✦ | 3.10M | — | $20.03M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 3.10M | — | $20.03M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Goldman Sachs Group ✦ | 3.10M | — | $20.03M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 1.45M | +72.7% | $12.63M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passive) | 1.45M | +72.7% | $12.63M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Oaktree Capital Management ✦ | 1.27M | 0.0% | $8.19M | 0.2% | Held | 6 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 1.18M | +55.7% | $7.64M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 932.62K | +60.3% | $6.01M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 932.62K | +60.3% | $6.01M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | GAMCO Investors ✦ | 906.04K | -9.1% | $5.84M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 16 | Marshall Wace ✦ | 813.08K | +626.0% | $5.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 652.63K | +237.1% | $4.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 556.16K | — | $3.59M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 556.16K | — | $3.59M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 556.16K | — | $3.59M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 556.16K | — | $3.59M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 556.16K | — | $3.59M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 556.16K | — | $3.59M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 556.16K | — | $3.59M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 556.16K | — | $3.59M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 489.56K | — | $3.16M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 489.56K | — | $3.16M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 489.56K | — | $3.16M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 489.56K | — | $3.16M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 489.56K | — | $3.16M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 489.56K | — | $3.16M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 489.56K | — | $3.16M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 489.56K | — | $3.16M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Millennium Management ✦ | 469.87K | -15.5% | $3.03M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | Bridgewater Associates ✦ | 436.55K | -41.4% | $2.82M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | Point72 Asset Management ✦ | 270.00K | New | $1.74M | 0.0% | New | 1 | SEC ↗ |
| 37 | Arrowstreet Capital ✦ | 205.59K | -88.3% | $1.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 38 | BlackRock ✦ (passive) | 131.00K | +31.6% | $844,943 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | BlackRock ✦ (passive) | 131.00K | +31.6% | $844,943 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | BlackRock ✦ (passive) | 131.00K | +31.6% | $844,943 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | Third Point ✦ | 100.00K | New | $645,000 | 0.0% | New | 1 | SEC ↗ |
| 42 | Gotham Asset Management ✦ | 57.02K | -24.4% | $367,805 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 27.58K | +26.4% | $177,891 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | Citadel Advisors ✦ | 27.58K | +26.4% | $177,891 | 0.0% | ▲ Add | 6 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $1.74M | 0.0% |
| Third Point | $645,000 | 0.0% |
Exited
| Icahn Capital | $231.24M | was 2.9% |
| Norges Bank | $116,657 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 224 holders, 232.19M shares, $1.23B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 36.83K sh · $258,894
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology